American Heart Association (AHA) Scientific Sessions 2021

Virtual 13 November 2021 - 15 November 2021

No reduction in COVID-19 hospitalization, death with icosapent ethyl

04 Jan 2022 bởi

Treatment with icosapent ethyl did not reduce the rate of hospitalization or mortality among patients with SARS-CoV-2 infection, according to results of the PREPARE IT-2* trial presented at AHA 2021.

No reduction in COVID-19 hospitalization, death with icosapent ethyl

04 Jan 2022

Coffee good – or bad – for the heart

20 Dec 2021 bởi

Daily coffee intake is tied to increased physical activity and incidence of premature ventricular contractions (PVCs) but fewer episodes of supraventricular tachycardia (SVT) and less nighttime sleep in the CRAVE* trial.

Coffee good – or bad – for the heart

20 Dec 2021

Dabigatran or warfarin: Choice does not matter in GIRAF

16 Dec 2021 bởi

The choice of oral anticoagulant does not appear to influence the outcome in terms of preserving cognitive function in older patients with atrial fibrillation (AF), the GIRAF* study has shown.

Dabigatran or warfarin: Choice does not matter in GIRAF

16 Dec 2021

No penalty to early CABG after stopping ticagrelor

11 Dec 2021 bởi

Undergoing CABG* within 2 to 3 days after stopping the antiplatelet ticagrelor does not increase the risk of severe/massive bleeding compared with delaying surgery until 5 to 7 days of ticagrelor discontinuation in patients with ACS**, according to the RAPID CABG *** study presented at AHA 2021.

No penalty to early CABG after stopping ticagrelor

11 Dec 2021

Low-dose aspirin does not stave off dementia

10 Dec 2021 bởi

A daily 100 mg dose of aspirin for 7 years did not reduce the risk of dementia in individuals with diabetes and no history of cardiovascular disease (CVD), according to results of the ASCEND* study presented at AHA 2021.

Low-dose aspirin does not stave off dementia

10 Dec 2021

Evinacumab reduces LDL-C levels in homozygous FH

09 Dec 2021 bởi

Treatment with evinacumab, an angiopoietin-like protein 3 (ANGPTL3) inhibitor, reduces low-density lipoprotein cholesterol (LDL-C) levels in adolescents and adults with homozygous familial hypercholesterolaemia (FH), according to a study presented at AHA 2021.

Evinacumab reduces LDL-C levels in homozygous FH

09 Dec 2021

Empagliflozin beneficial and well tolerated in acute heart failure

06 Dec 2021 bởi

Empagliflozin provides a significant clinical benefit within 90 days and shows no safety concerns in patients hospitalized for acute heart failure (HF), according to results of the EMPULSE trial reported at the American Heart Association (AHA) Scientific Sessions 2021.

Empagliflozin beneficial and well tolerated in acute heart failure

06 Dec 2021

Canagliflozin improves HF symptoms, QoL regardless of diabetes status

04 Dec 2021 bởi

The SGLT2i* canagliflozin significantly improves symptoms and quality of life (QoL) early on during treatment in people with heart failure (HF) due to either reduced or preserved ejection fraction (rEF or pEF), regardless of whether they have type 2 diabetes (T2D), according to the CHIEF-HF** study presented at AHA 2021.

Canagliflozin improves HF symptoms, QoL regardless of diabetes status

04 Dec 2021

Inclisiran sustains LDL-C reduction in high-risk patients with ASCVD

03 Dec 2021 bởi

Treatment with inclisiran consistently reduced low-density lipoprotein cholesterol (LDL-C) levels in patients with, or at high risk of, atherosclerotic cardiovascular disease (ASCVD), regardless of glycaemic status, based on a pooled analysis of the ORION-10* and ORION-11** studies presented at AHA 2021.

Inclisiran sustains LDL-C reduction in high-risk patients with ASCVD

03 Dec 2021

Milvexian prevents VTE after knee arthroplasty, bleeding risk low

02 Dec 2021 bởi

Postoperative treatment with the oral factor XIa inhibitor milvexian could help prevent the incidence of venous thromboembolism (VTE) in patients undergoing elective knee arthroplasty, according to results of a phase II trial presented at AHA 2021.

Milvexian prevents VTE after knee arthroplasty, bleeding risk low

02 Dec 2021